drugset / Trial / NCT07239453

Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects

NCT07239453 ↗

Phase 1 Completed 40 enrolled Dong-A ST Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This study is to compare pharmacokinetics and safety profiles of DA-2902 and DA-2902-R in healthy adult subjects

Timeline

Start
2025-11-07
Primary completion
2025-11-18
Completion
2025-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-2902 Unknown — Oral
Subject DA-2902-R Unknown — Oral

Indications